Fosaprepitant for Injection 150 mg per vial recall: Sterility Concern
Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.
Why was Fosaprepitant for Injection 150 mg per vial recalled?
Lack of Sterility Assurance: Aseptic process simulation failure.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
lot #13D012AA, Exp: 08/31/2025
- Product
- Fosaprepitant for Injection 150 mg per vial, Sterile lyophilized powder for Intravenous use only after reconstitution and dilution, Single Dose Vial, Rx Only, Distributed by BE Pharmaceuticals Inc. 203 New Edition Court Cary, NC 27511, Made in India, NDC 71839-104-01.
- Recalling firm
- BE PHARMACEUTICALS AG
- Quantity
- 22,176 Vials
- Distribution
- Nationwide in the USA
- Recall date
- January 31, 2024
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)